Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DexCom Inc (NASDAQ:DXCM)

92.23
Delayed Data
As of Jul 29
 +2.67 / +2.98%
Today’s Change
47.92
Today|||52-Week Range
103.29
+12.61%
Year-to-Date
Strength Seen in Dexcom (DXCM) Soars: Stock Soars 6.2%
Jul 20 / Zacks.com - Paid Partner Content
Why MGIC Investment, Dexcom, and F5 Networks Jumped Today
Jul 19 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close89.56
Today’s open90.33
Day’s range89.70 - 92.39
Volume882,846
Average volume (3 months)904,804
Market cap$7.4B
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-140.00%
Earnings growth (this year)-35.88%
Earnings growth (next 5 years)+32.50%
Revenue growth (last year)+55.09%
P/E ratioNM
Price/Sales16.26
Price/Book32.75

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...+0.28+0.35%
ABMDAbiomed Inc+2.94+2.56%
NUVANuVasive Inc+0.18+0.29%
IARTIntegra LifeSciences...+1.30+1.57%
Data as of 4:02pm ET, 07/29/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$402.0M
Annual profit (last year)-$57.6M
Net profit margin-14.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Kevin Ronald Sayer
Senior Vice President-
Operations
Jeffrey C. Moy
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs